ArticleFrontiers in microbiology2026
Subtype-associated gut microbial taxa and their clinical correlates in acute ischemic stroke: comparison of large-artery atherosclerosis and small-vessel occlusion.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The gut microbiome gets altered during ischemic stroke (IS); however, whether distinct microbial signatures characterize specific IS subtypes, such as large-artery atherosclerosis (LAA) and small-vessel occlusion (SVO), and their relation to subtype-specific clinical features, remains unclear. This study aimed at comparing gut microbiome profiles among patients with LAA, patients with SVO, and healthy controls (HCs); further, the associations between subtype-enriched microbial taxa and clinical parameters were examined. Methods: We compared gut microbiome profiles and clinical associations among patients with LAA, patients with SVO, and HCs ( Results: Linear discriminant analysis effect size analysis showed that, compared with HCs, patients with IS had reduced alpha diversity and distinct beta diversity. No significant differences were observed between patients with LAA and SVO in alpha diversity (all indices, Conclusion: Although overall microbial diversity did not differ between patients with LAA and SVO, subtype-enriched taxa were associated with distinct clinical features. These findings support the presence of subtype-specific microbial patterns that may reflect different pathophysiological processes; however, causal relationships remain to be established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.